Particularly high and frequent expression of CA IX is present in renal cell carcinomas, where the CA IX-specific monoclonal antibody G250 is evaluated as a promising tool for immunotherapy (Oosterwijk-Wakka et al., 2013). The gene discussed is CA9; the disease is renal cell carcinoma.